Analysis of clinical utility of abdominopelvic computed tomography in the follow-up of Stage I seminoma: a single center evaluation.


Journal

Minerva urology and nephrology
ISSN: 2724-6442
Titre abrégé: Minerva Urol Nephrol
Pays: Italy
ID NLM: 101777299

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 14 12 2019
medline: 14 7 2021
entrez: 14 12 2019
Statut: ppublish

Résumé

Abdominopelvic computed tomography (CT) is widely used in the follow-up of seminoma patients after radical orchidectomy. The aim of this study was to evaluate the clinical utility of abdominopelvic computed tomography in the follow-up of patients with Stage I seminoma. The pathological reports of all patients that have undergone radical orchidectomy in our tertiary referral center between January 2002 and January 2018 have been retrospectively reviewed. All patients with Stage I seminoma and negative serum tumor markers after radical orchidectomy were included. Patients with follow-up shorter than 12 months were excluded. Surveillance records of every patient were reviewed with regard to abdominopelvic imaging. Of the 133 patients who have undergone radical orchidectomy in our center, 55 had Stage I pure seminoma with normal levels of serum tumor markers after surgery. Two patients were excluded as the follow-up was inadequate. Mean follow-up was 63.2 months (IQR: 30-73). The results of 211 abdominopelvic CTs performed as part of the follow-up were reviewed. Two (3,7%) patients developed recurrence; one consisted of a scrotal lump and was diagnosed with ultrasonography (US) while the second appeared as paraaortic nodal metastasis and was diagnosed with abdominopelvic CT. The recurrence was successfully treated in both patients. A single abdominopelvic CT was useful for the detection of recurrent disease in our entire study population. No cancer specific death has been reported in the study population. Follow-up schedules for Stage I seminoma expose patients to potential risks of radiation-induced tumors, emotional distress and represent a significant burden for the healthcare system. The current series suggests that a better risk adapted patient-tailored follow-up program is needed in order to avoid unnecessary investigations.

Sections du résumé

BACKGROUND
Abdominopelvic computed tomography (CT) is widely used in the follow-up of seminoma patients after radical orchidectomy. The aim of this study was to evaluate the clinical utility of abdominopelvic computed tomography in the follow-up of patients with Stage I seminoma.
METHODS
The pathological reports of all patients that have undergone radical orchidectomy in our tertiary referral center between January 2002 and January 2018 have been retrospectively reviewed. All patients with Stage I seminoma and negative serum tumor markers after radical orchidectomy were included. Patients with follow-up shorter than 12 months were excluded. Surveillance records of every patient were reviewed with regard to abdominopelvic imaging.
RESULTS
Of the 133 patients who have undergone radical orchidectomy in our center, 55 had Stage I pure seminoma with normal levels of serum tumor markers after surgery. Two patients were excluded as the follow-up was inadequate. Mean follow-up was 63.2 months (IQR: 30-73). The results of 211 abdominopelvic CTs performed as part of the follow-up were reviewed. Two (3,7%) patients developed recurrence; one consisted of a scrotal lump and was diagnosed with ultrasonography (US) while the second appeared as paraaortic nodal metastasis and was diagnosed with abdominopelvic CT. The recurrence was successfully treated in both patients. A single abdominopelvic CT was useful for the detection of recurrent disease in our entire study population. No cancer specific death has been reported in the study population.
CONCLUSIONS
Follow-up schedules for Stage I seminoma expose patients to potential risks of radiation-induced tumors, emotional distress and represent a significant burden for the healthcare system. The current series suggests that a better risk adapted patient-tailored follow-up program is needed in order to avoid unnecessary investigations.

Identifiants

pubmed: 31833335
pii: S0393-2249.19.03562-8
doi: 10.23736/S2724-6051.19.03562-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-89

Auteurs

Michele Rizzo (M)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy - mik.rizzo@gmail.com.

Luca Ongaro (L)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Francesco Claps (F)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Dario Ghassempour (D)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Enrica Verzotti (E)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Francesca Migliozzi (F)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Matteo Boltri (M)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Nicola Pavan (N)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Giulio Garaffa (G)

The Institute of Urology, University College London Hospitals, London, UK.

Stefano Bucci (S)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Paolo Umari (P)

Department of Surgery, Clinic of Urology, University of Eastern Piedmont, Novara, Italy.

Carlo Trombetta (C)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Giovanni Liguori (G)

Department of Medicine, Surgery and Health Sciences, Clinic of Urology, University of Trieste, Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH